Press release
Enteric Disease Testing Market Size (USD 5.3 Billion by 2032) Achieves Record-breaking Growth in Meeting Healthcare Requirements
Enteric Disease Testing Market
The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.
๐๐ฆ๐ฉ๐๐๐ญ ๐จ๐ ๐๐จ๐ฏ๐ข๐-๐๐ ๐จ๐ง ๐๐ง๐ญ๐๐ซ๐ข๐ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ
โข Due to the COVID-19 pandemic and the subsequent global lockdowns, the enteric disease testing market faced a downturn.
โข However, as the global situation started ameliorating, the demand for enteric disease testing product was restored back. This, in turn, presented various growth opportunities for companies operating in the enteric disease testing market.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐:
https://www.alliedmarketresearch.com/request-sample/295
๐๐ก๐๐ญ ๐๐ซ๐ ๐ญ๐ก๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ ๐๐จ๐ซ ๐๐ง๐ญ๐๐ซ๐ข๐ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐๐ฌ๐ญ๐ข๐ง๐ ?
Increase in awareness in developing countries regarding diagnosis of infectious enteric diseases, easy availability of testing reagents of enteric disease, and technological advancement in testing equipment of enteric diseases drive the growth of the global enteric disease testing market. However, the high cost associated with molecular diagnostic assay is hampering the enteric disease testing market growth. On the contrary, the increase in adoption of key strategies by key players is expected to offer remunerative opportunities for expansion of the enteric disease testing market during the forecast period.
๐๐จ๐ฉ ๐๐ง๐ญ๐๐ซ๐ข๐ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ
โข Abbott Laboratories
โข Becton Dickinson & Company
โข Biomerica Inc.
โข Biomerieux SA
โข Bio-Rad Laboratories Inc.
โข Coris Bioconcept
โข Diasorin S.p.A.
โข Meridian Bioscience Inc
โข Quest Diagnostics
โข Trinity
๐๐ง๐ญ๐๐ซ๐ข๐ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ณ๐ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง: -
Based on product type, the reagents and
consumables segment held the highest market share in 2022, accounting for more than two-thirds of the global enteric disease testing market revenue and is estimated to maintain its leadership status throughout the forecast period, owing to rise in number of market players who manufactures reagents and consumables and increase in awareness among people regarding use of kits for diagnosis of enteric disease.
Based on technique, the immunodiagnostics segment held the highest market share in 2022, accounting for more than three-fifths of the global enteric disease testing market revenue and is estimated to maintain its leadership status throughout the forecast period, owing to high adoption of immunodiagnostics technique and increase in technological advancement in immunodiagnostic technique.
Based on end user, the hospital laboratories segment held the highest market share in terms of revenue in 2022, accounting for around four-fifths of the global enteric disease testing market revenue, and is estimated to maintain its leadership status throughout the forecast period.
Based on region, North America held the highest market share in terms of revenue in 2022, accounting for nearly two-fifths of the global enteric disease testing market revenue and is estimated to maintain its leadership status throughout the forecast period, owing to robust healthcare infrastructure, presence of key players, and rise in healthcare expenditure. However, the Asia-Pacific region is expected to witness the fastest CAGR of 5.2% from 2023 to 2032, owing to an increase in awareness related to use of enteric disease testing products, unmet medical demands, and high population base.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.alliedmarketresearch.com/purchase-enquiry/295
Our Market Research Solution Provides You Answer to Below Mentioned Question:
โข Which are the driving factors responsible for the growth of market?
โข Which are the roadblock factors of this market?
โข What are the new opportunities, by which market will grow in coming years?
โข What are the trends of this market?
โข Which are main factors responsible for new product launch?
โข How big is the global & regional market in terms of revenue, sales and production?
โข How far will the market grow in forecast period in terms of revenue, sales and production?
โข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
โข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โข Which region has more opportunities?
By Region Outlook
โข North America
(U.S., Canada, Mexico)
โข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Enteric Disease Testing Market Size (USD 5.3 Billion by 2032) Achieves Record-breaking Growth in Meeting Healthcare Requirements here
News-ID: 3170142 • Views: โฆ
More Releases from Allied Market Research (AMR)
Urban Air Mobility (UAM) Market is likely to grow at a CAGR of 30.2% through 203 โฆ
According to a new report published by Allied Market Research, titled, "Urban Air Mobility(UAM) Market," The urban air mobility(uam) market size was valued at $2.3 billion in 2021, and is estimated to reach $30.7 billion by 2031, growing at a CAGR of 30.2% from 2022 to 2031.
Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/6808
Urban air mobility is now proving to be a practical means of transport forโฆ
Fiber Cement Market Analysis 2026-2030 Global Size, Segmentation Outlook, and Gr โฆ
The rising need to reduce carbon emissions from the building and construction sector is significantly driving the growth of the global fiber cement market. As sustainability becomes a core focus across industries, fiber cement is emerging as a preferred material due to its durability, energy efficiency, and eco-friendly properties.
According to a report published by Allied Market Research titled "Fiber Cement Market by Raw Material (Portland Cement, Silica, Cellulosic Fibers, andโฆ
Adhesives and Sealants Market Outlook 2026-2030 Industry Trends, Market Share, a โฆ
The global adhesives and sealants market is witnessing steady growth, driven by rapid technological advancements, increasing R&D activities, and rising demand for electrical & electronic devices. In addition, growing government investments in building and construction projects across emerging and developed economies are significantly fueling market expansion.
According to a report published by Allied Market Research, the market was valued at $51.9 billion in 2020 and is projected to reach $85.0 billionโฆ
Salicylic Acid Market Analysis 2026-2030 Global Size, Growth Trends and Competit โฆ
The global salicylic acid market is witnessing steady growth, driven by rising demand from the preserved food & beverage industry and the expanding personal care sector. Increasing adoption in pharmaceuticals and cosmetics further strengthens market expansion.
According to Allied Market Research, the market was valued at $431.7 million in 2020 and is projected to reach $886.9 million by 2030, growing at a CAGR of 7.5% from 2020 to 2030.
Download Sample Pagesโฆ
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease โฆ
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.โฆ
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas โฆ
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by theโฆ
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind โฆ
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohnโs Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcoholโฆ
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, andโฆ
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing geneโฆ
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news andโฆ
